Cargando…
Pyridinium crosslinks as markers of bone resorption in patients with breast cancer.
Collagen breakdown, and thus bone resorption, can now be assessed by measuring the urinary excretion of the collagen crosslinks, pyridinoline (Pyd) and deoxypyridinoline (Dpd). In a pilot study we measured Pyd and Dpd in 20 patients with breast cancer, ten with known bone metastases and ten with no...
Autores principales: | Paterson, C. R., Robins, S. P., Horobin, J. M., Preece, P. E., Cuschieri, A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977489/ https://www.ncbi.nlm.nih.gov/pubmed/1931610 |
Ejemplares similares
-
Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone disease.
por: Coleman, R. E., et al.
Publicado: (1992) -
Comparative evaluation of markers of bone resorption in patients with breast cancer-induced osteolysis before and after bisphosphonate therapy.
por: Body, J. J., et al.
Publicado: (1997) -
Response of Bone Resorption Markers to Aristolochia longa Intake by Algerian Breast Cancer Postmenopausal Women
por: Benarba, Bachir, et al.
Publicado: (2014) -
Cellular mechanisms of bone resorption in breast carcinoma
por: Hunt, N C A, et al.
Publicado: (2001) -
Effects on bone resorption markers of continuing pamidronate or switching to zoledronic acid in patients with high risk bone metastases from breast cancer
por: Hilton, J.F., et al.
Publicado: (2017)